Other biomarkers of systemic inflammation, such as erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), glucose, neutrophils, and neutrophil/lymphocyte ratio, are found to be increased in COVID-19 patients with myocardial injury. The gene discussed is CRP; the disease is COVID-19.